Mark Moglowsky
Gastroenterology · Huntsville, ALNPI 1679527485
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 559 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 25.7% of the total. Reporting peaked in 2022 at $2,040 and has fallen 97.2% since, to $57 in 2025.
Across 559 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$575
- QOL Medical, LLC$266
- Nestle Healthcare Nutrition Inc.$266
- plus $2K from 19 others
What the payments were for
- Food & beverage$8,35599%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 164 | $2,159 |
| AbbVie(2 entities) | 128 | $2,069 |
| Johnson & Johnson | 94 | $1,389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $575 |
| QOL Medical, LLC | 15 | $266 |
| Nestle Healthcare Nutrition Inc. | 25 | $266 |
| Ironwood Pharmaceuticals, Inc | 16 | $264 |
| Merck | 14 | $256 |
| Gilead | 12 | $203 |
| Intercept Pharmaceuticals, Inc. | 10 | $154 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| Ferring Pharmaceuticals Inc. | 8 | $134 |
| Redhill Biopharma Inc. | 7 | $110 |
| UCB, Inc. | 7 | $94 |
| Boston Scientific | 2 | $72 |
| Sanofi | 3 | $66 |
| Intra-sana Laboratories | 2 | $36 |
| Pfizer | 2 | $33 |
| Bristol Myers Squibb | 2 | $29 |
| Evoke Pharma, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $18 |
| Micro-tech Endoscopy USA, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$8,412 in reported general payments places this provider in the 75th percentile of 225 gastroenterology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 42 | $544 |
| Omeprazole | 19 | $284 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Huntsville
- John-Paul VoelkelHuntsville$17K
- Meredith RoathHuntsville$16K
- Charles BillingsHuntsville$16K
- Dino FerranteHuntsville$15K
- Suresh KarneHuntsville$12K
- Rami HawariHuntsville$10K
- Prasad VankineniHuntsville$10K
- Eghierhua UgheokeHuntsville$10K
- Jason KinzelHuntsville$10K
- Keta VaidyaHuntsville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.